FIELD: genetic engineering.
SUBSTANCE: invention relates to vectors used in genetic engineering. Invention proposes a lentiviral vector with condition-dependent replication that comprises two nucleotide sequences. The first nucleotide sequence reduces probability for formation of lentiviral vector able for replication. The second nucleotide sequence inhibits replication of lentivirus of wild type, helper virus or helper vector but it doesn't inhibit replication of dependent vectors, or it encodes proteins showing the same properties. Also, invention discloses these nucleotide sequences, method for preparing such vectors and their using. Invention can be used in medicine in prophylaxis and therapeutic treatment of viral diseases, in particular, HIV infection.
EFFECT: valuable biological properties of vectors.
45 cl, 53 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
RECESSIVE DIVIDING RETROVIRAL VECTOR (VARIANTS), METHOD FOR PRODUCTION THEREOF (VARIANTS), ISOLATED AND PURIFIED NUCLEIC ACID MOLECULE | 1996 |
|
RU2270250C2 |
METHOD FOR TEMPORARY TRANSFECTION FOR PRODUCING RETROVIRUS | 2016 |
|
RU2749717C2 |
STABLE CELL LINES FOR RETROVIRUSES PRODUCTION | 2016 |
|
RU2752498C2 |
POLYVALENT VIRAL VECTORS AND SYSTEM FOR PRODUCING THEREOF | 2005 |
|
RU2416646C2 |
GENETIC MAKE-UPS FOR ANTI-HIV THERAPY | 2010 |
|
RU2426788C1 |
IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY | 2013 |
|
RU2533817C1 |
METHOD FOR STABLE CELL TRANSDUCTION BY VIRAL VECTORS | 2001 |
|
RU2280074C2 |
COMPOSITIONS AND METHODS OF GENETIC MATERIAL DELIVERY | 1994 |
|
RU2174845C2 |
CHIMERIC ANTIGENIC RECEPTORS WITH MND-PROMOTER | 2015 |
|
RU2708311C2 |
RNA-guided destruction of human JC virus and other poliomaviruses | 2015 |
|
RU2747722C2 |
Authors
Dates
2007-06-20—Published
2001-09-21—Filed